Published in
Wiley Open Access, Molecular Oncology, 1(8), p. 20-26, 2013
DOI: 10.1016/j.molonc.2013.08.013
Links
Tools
Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancer
Journal article published in 2013 by
Filippo Montemurro,
Aleix Prat,
Valentina Rossi,
Giorgio Valabrega,
Jeff Sperinde,
Caterina Peraldo-Neia 
,
Michela Donadio,
Patricia Galván ,
Anna Sapino,
Massimo Aglietta,
José Baselga,
Maurizio Scaltriti
,
Michela Donadio,
Patricia Galván ,
Anna Sapino,
Massimo Aglietta,
José Baselga,
Maurizio Scaltriti
This paper is made freely available by the publisher.
Full text: Download
Data provided by 